Safety and efficacy of 0.5% Podofilox gel in the treatment of anogenital warts

Archives of Dermatology

Volumn 134, Issue 1, 1998, Pages 33-38

  Tyring, Stephen ^a   Edwards, Libby ^b   Cherry, Lisa K ^b   Ramsdell, William M ^b   Kotner, Steven ^b   Greenberg, Mitchell D ^b   Corwin Vance, J ^b   Barnum, Gail ^b   Dromgoole, Sydney H ^b   Killey, Frank P ^b   Toter, Tanya ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; PODOPHYLLOTOXIN;

ADULT; ARTICLE; BURN; CLINICAL PROTOCOL; CLINICAL TRIAL; CONDYLOMA; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; GEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN INFLAMMATION; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; ANUS DISEASES; CONDYLOMATA ACUMINATA; DOUBLE-BLIND METHOD; DRUG ERUPTIONS; FEMALE; GELS; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HEADACHE; HUMANS; KERATOLYTIC AGENTS; MALE; PODOPHYLLOTOXIN; PRURITUS; SAFETY; SENSATION DISORDERS; TREATMENT OUTCOME; VEHICLES;

EID: 0031934202     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.1.33     Document Type: Article

References (19)

1. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev. 1988;10:122-163.
2. Luchtefeld MA. Perianal condylomata acuminata. Surg Clin North Am. 1994;74:1327-1338.
3. Human papillomavirus infection: sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep. 1993;2:83-88.
4. Ferenczy A. Epidemiology and clinical pathophysiology of condyloma acuminata. Am J Obstet Gynecol. 1995;172:1331-1339.
5. von Krogh G. Topical treatment of outer genital warts. Cervix Lower Genital Tract. 1992;10:125-131.
6. Lassus A, Haukka K, Forsstrom S. Podophyllotoxin for treatment of genital warts in males: a comparison with conventional podophyllin therapy. Eur J Sex Trans Dis. 1984;2:31-33.
7. Edwards A, Atma-Ram A, Nicol Thin R. Podophyllotoxin 0.5% v podophyllin 20% to treat penile warts. Genitourin Med. 1988;64:263-265.
8. Kinghorn GR, McMillan A, Mulcahy F, et al. An open, comparative study of the efficacy of 0.5% podophyllotoxin lotion and 25% podophyllotoxin solution in the treatment of condylomata acuminata in males and females. Int J STD AIDS. 1993;4:194-199.
9. Beutner KR, Conant MA, Friedman-Kien AE, et al. Patient-applied podofilox for treatment of genital warts. Lancet, 1989;1:831-834.
10. Kirby P, Dunne A, King DH, et al. Double-blind randomized clinical trial of self-administered podofilox solution versus vehicle in the treatment of genital warts. Am J Med. 1990;88:465-469.
11. Baker DA, Douglas JM, Buntin DM, et al. Topical podophyllotoxin for the treatment of condyloma acuminata in women. Obstet Gynecol. 1991;76:654-659.
12. Greenberg MD, Rutledge LH, Reid R, et al. A double-blind randomized trial of 0.5% podofilox and placebo for the treatment of genital warts in women. Obstet Gynecol, 1991;77:735-739.
13. Rosenberg MJ, Long SC, Adair DW, et al. Patient-applied treatment for genital warts: experience from a large post-marketing study. J Dermatol Treat. 1995;6:223-226.
14. Petersen CS, Agner T, Ottevanger V, et al. A single-blind study of podophyllotoxin cream 0.5% and podophyllotoxin solution 0.5% in male patients with genital warts. Genitourin Med. 1995;71:391-392.
15. Strand A, Brinkeborn R-M, Siboulet A. Topical treatment of genital warts in men: an open study of podophyllotoxin cream 0.5% compared with solution. Genitourin Med. 1995;71:387-390.
16. Hellberg D, Svarrer T, Nilsson S, et al. Self-treatment of female external genital warts with 0.5% podophyllotoxin cream (Condyline) vs weekly applications of 20% podophyllin solution. Int J STD AIDS. 1995;4:257-261.
17. Syed TA, Cheema KM, Khayyami M, et al. Human leukocyte interferon-alpha versus podophyllotoxin in cream for the treatment of genital warts in males. Dermatology. 1995;191:129-132.
18. Syed TA, Lundin S, Ahmad SA. Topical 0.3% and 0.5% podophyllotoxin cream for the self-treatment of condylomata acuminata in women. Dermatology. 1994;189:142-145.
19. Petersen CS, Weismann K. Quercetin and kaempherol: an argument against the use of podophyllin? Genitourin Med. 1995;71:92-93.